Planned enrollment increased by 21 participants
Before: 12 participants (planned). After: 33 participants (planned).
Primary completion date changed
Before: Dec 2025. After: Jun 2027.
Study sponsor: Arcturus Therapeutics, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 12 participants (planned). After: 33 participants (planned).
Before: Dec 2025. After: Jun 2027.